agilon health, inc.
AGL
$2.97
$0.082.77%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 111.45% | 10.05% | -283.34% | -405.97% | 97.37% |
| Total Depreciation and Amortization | 5.88% | 4.44% | 5.26% | 1.08% | 23.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -222.42% | -13.91% | 15.18% | -36.40% | -77.10% |
| Change in Net Operating Assets | -136.68% | 14.79% | 2,416.72% | 93.72% | -166.23% |
| Cash from Operations | -294.82% | 313.15% | 58.84% | 60.82% | 21.89% |
| Capital Expenditure | -17.85% | 7.58% | -6.70% | -5.51% | 20.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.42% | -46.23% | 132.70% | -60.55% | 17,562.46% |
| Cash from Investing | -197.53% | -49.16% | 155.60% | -64.58% | 2,434.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | 346.67% |
| Repurchase of Common Stock | -- | 85.90% | 66.38% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -631.82% | 98.44% | 17.97% | -406.62% | 166.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.85% | 6.98% | 1,791.69% | -152.45% | 106.57% |